New Jersey Innovation Institute Recruiting Seventh Cohort for Health IT Connections Program—Business Development for “Scale-up” Health IT Companies

Published on:

The New Jersey Innovation Institute is calling for applications to participate in the seventh cycle of the successful Health IT Connections program, set to kick off October 6, 2017.

The Health IT Connections program was established in 2014 to grow the health IT cluster in the region by supporting growth-stage health IT entrepreneurs through intensive training and mentoring. In addition, the program helps drive cluster growth by connecting businesses to new customers, strategic partners and suppliers. The program is funded in part from JPMorgan Chase’s Small Business ForwardSM initiative. No fees or equity is required by entrepreneurs to participate.

 Now in its fourth year, the Health IT Connections program has successfully helped 75 companies develop new partnerships and connect to new business opportunities. Reporting companies achieved annualized revenue and job growth of 46 percent and 42 percent respectively. The Health IT Connections program has helped to develop the overall regional cluster by having hosted and sponsored more than 20 events, including a private pitch session for executives at a regional medical center.

 Judith Sheft, Associate vice president of Technology and Enterprise Development at NJII and the recipient of the grant notes, “The primary goal of our program is the growth and development of the Health IT sector in the greater NJ/NY region. As a nonprofit entity funded from outside the industry, we can serve as an honest broker between the healthcare organizations in need of 21st century solutions—hospitals, big pharma, insurers and the entrepreneurs who are developing tomorrow’s innovations.”

 Applications are currently open for Cohort 7 of the Health IT Connections program, slated to meet every other Friday from Oct. 6 to Dec. 15 (no relocation required). For more information visit www.njii.com/healthit   Applications available at https://judithsheft.wufoo.com/forms/z669z3a1j1u3bk/.

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.